Stratec Biomedical Stock Price, News & Analysis (ETR:SBS)

€72.10 +0.30 (+0.42 %)
(As of 02/23/2018 01:24 PM ET)
Previous Close€71.80
Today's Range€72.00 - €72.70
52-Week Range€45.67 - €74.60
Volume2,281 shs
Average Volume8,402 shs
Market Capitalization$859.50 million
P/E Ratio31.48
Dividend Yield1.07%
BetaN/A

About Stratec Biomedical (ETR:SBS)

Stratec Biomedical logoSTRATEC Biomedical AG designs and manufactures solutions for automated processes in the fields of in vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Consumables segment develops and sells scientific materials, such as nucleic acid purification; and designs and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC Biomedical AG also develops workflow software for networking several analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical Systems AG and changed its name to STRATEC Biomedical AG in April 2011. STRATEC Biomedical AG was founded in 1979 and is headquartered in Birkenfeld, Germany.

Receive SBS News and Ratings via Email

Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolETR:SBS
CUSIPN/A
Phone+49-7082-79160

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio31.4847161572052
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS€2.29
Net IncomeN/A
Net Margins18.89%
Return on Equity26.35%
Return on Assets15.03%

Miscellaneous

EmployeesN/A
Outstanding Shares11,910,000

Stratec Biomedical (ETR:SBS) Frequently Asked Questions

What is Stratec Biomedical's stock symbol?

Stratec Biomedical trades on the ETR under the ticker symbol "SBS."

Where is Stratec Biomedical's stock going? Where will Stratec Biomedical's stock price be in 2018?

6 brokers have issued 1 year target prices for Stratec Biomedical's stock. Their forecasts range from €58.00 to €70.00. On average, they anticipate Stratec Biomedical's stock price to reach €61.50 in the next year. View Analyst Ratings for Stratec Biomedical.

Who are some of Stratec Biomedical's key competitors?

Who are Stratec Biomedical's key executives?

Stratec Biomedical's management team includes the folowing people:

  • Fred K. Brueckner, Chairman of the Supervisory Board (Age 74)
  • Marcus Wolfinger, Chairman of the Management Board, Chief Executive Officer (Age 50)
  • Rainer Baule, Vice Chairman of the Supervisory Board
  • Robert Siegle, Director of Finance and Human Resources, Member of the Board of Management (Age 50)
  • Claus Vielsack, Member of the Management Board, Director of Product Development (Age 50)
  • Stefanie Remmele, Member of the Supervisory Board (Age 39)

What is Stratec Biomedical's stock price today?

One share of Stratec Biomedical stock can currently be purchased for approximately €72.10.

How big of a company is Stratec Biomedical?

Stratec Biomedical has a market capitalization of $859.50 million.

How can I contact Stratec Biomedical?

Stratec Biomedical's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160.


MarketBeat Community Rating for Stratec Biomedical (SBS)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  86 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  123
MarketBeat's community ratings are surveys of what our community members think about Stratec Biomedical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Stratec Biomedical (ETR:SBS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.332.40
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €61.50€61.50€60.50€60.00

Stratec Biomedical (ETR:SBS) Consensus Price Target History

Price Target History for Stratec Biomedical (ETR:SBS)

Stratec Biomedical (ETR:SBS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
1/22/2018Deutsche BankSet Price TargetNeutral€62.00View Rating Details
12/7/2017Berenberg BankSet Price TargetNeutral€59.00View Rating Details
10/27/2017Kepler Capital MarketsSet Price TargetBuy€70.00View Rating Details
10/26/2017Warburg ResearchSet Price TargetBuy€62.00View Rating Details
10/23/2017Oddo BhfSet Price TargetNeutral€58.00View Rating Details
7/24/2017Oddo SecuritiesSet Price TargetNeutral€58.00View Rating Details
(Data available from 2/23/2016 forward)

Earnings

Earnings History for Stratec Biomedical (ETR:SBS)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Stratec Biomedical (ETR:SBS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Stratec Biomedical (ETR:SBS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Stratec Biomedical (ETR SBS)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

Stratec Biomedical (ETR SBS) News Headlines

Source:
DateHeadline
Stratec Biomedical AG (SBS) Given Consensus Rating of "Hold" by AnalystsStratec Biomedical AG (SBS) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - January 31 at 1:34 AM
Stratec Biomedical (SBS) Given a €62.00 Price Target at Deutsche BankStratec Biomedical (SBS) Given a €62.00 Price Target at Deutsche Bank
www.americanbankingnews.com - January 22 at 9:20 AM
Stratec Biomedical AG (SBS) Receives Average Recommendation of "Hold" from AnalystsStratec Biomedical AG (SBS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 6 at 1:26 AM
Stratec Biomedical AG (SBS) Given Consensus Recommendation of "Hold" by BrokeragesStratec Biomedical AG (SBS) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - December 12 at 1:56 AM
Berenberg Bank Reiterates "€59.00" Price Target for Stratec Biomedical (SBS)Berenberg Bank Reiterates "€59.00" Price Target for Stratec Biomedical (SBS)
www.americanbankingnews.com - December 7 at 8:34 AM
Stratec Biomedical AG (SBS) Given Average Rating of "Hold" by BrokeragesStratec Biomedical AG (SBS) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - November 17 at 1:48 AM
Kepler Capital Markets Analysts Give Stratec Biomedical AG (SBS) a €70.00 Price TargetKepler Capital Markets Analysts Give Stratec Biomedical AG (SBS) a €70.00 Price Target
www.americanbankingnews.com - October 27 at 10:34 AM
Deutsche Bank AG Analysts Give Stratec Biomedical AG (SBS) a €56.00 Price TargetDeutsche Bank AG Analysts Give Stratec Biomedical AG (SBS) a €56.00 Price Target
www.americanbankingnews.com - October 24 at 12:48 PM
Stratec Biomedical AG (SBS) Given a €57.00 Price Target by Berenberg Bank AnalystsStratec Biomedical AG (SBS) Given a €57.00 Price Target by Berenberg Bank Analysts
www.americanbankingnews.com - October 23 at 6:44 AM
Stratec Biomedical AG (SBS) Given a €55.00 Price Target at Deutsche Bank AGStratec Biomedical AG (SBS) Given a €55.00 Price Target at Deutsche Bank AG
www.americanbankingnews.com - July 27 at 11:51 AM
Stratec Biomedical AG (ETR:SBS) Given a €66.00 Price Target by Kepler Capital Markets AnalystsStratec Biomedical AG (ETR:SBS) Given a €66.00 Price Target by Kepler Capital Markets Analysts
www.americanbankingnews.com - July 26 at 11:47 AM
Stratec Biomedical AG (SBS) PT Set at €62.00 by Warburg ResearchStratec Biomedical AG (SBS) PT Set at €62.00 by Warburg Research
www.americanbankingnews.com - July 25 at 12:13 PM
Stratec Biomedical AG (SBS) PT Set at €59.00 by Berenberg BankStratec Biomedical AG (SBS) PT Set at €59.00 by Berenberg Bank
www.americanbankingnews.com - July 25 at 10:19 AM
Stratec Biomedical AG (SBS) Given a €58.00 Price Target at Oddo SecuritiesStratec Biomedical AG (SBS) Given a €58.00 Price Target at Oddo Securities
www.americanbankingnews.com - July 24 at 11:02 AM

SEC Filings

Stratec Biomedical (ETR:SBS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Stratec Biomedical (ETR SBS) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.